
LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. (LENZ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LENZ · as of Jun 8, 2026
Key Statistics
Explore LENZ Therapeutics, Inc. Data
lenz stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 5 · Buy rate: 80.0%
The LENZ analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +78.57% upside from the current price of $6.72.
Competitors & Peers
lenz competitorsStock Performance
Full HistoryAbout LENZ Therapeutics, Inc.
LENZ Therapeutics, Inc. is a biopharmaceutical firm whose primary mission involves the advancement and commercialization of new treatments designed to enhance vision for individuals in the United Stat…
what is lenz therapeutics, inc. · lenz stock overview · lenz therapeutics, inc. company profile · who is lenz therapeutics, inc. ceo · lenz NASDAQ · lenz therapeutics, inc. headquarters · lenz therapeutics, inc. business segments
About Stock Overview & Key Data
LENZ Therapeutics, Inc. (LENZ) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 22, 2024. As of the latest trading session, LENZ stock price is $6.72, with a market capitalization of $210.7M. The stock has returned -78.39% over the past 12 months and -57.83% year-to-date.
According to 5 Wall Street analysts, the consensus rating for LENZ Therapeutics, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, LENZ Therapeutics, Inc. reported revenue of $19.1M and net income of -$82.1M. For detailed data — including LENZ Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, LENZ Therapeutics, Inc. (LENZ) stock price is $6.72. The stock is traded on NASDAQ under the ticker symbol LENZ. The 52-week range is $6.61 – $50.40.